0.26Open0.26Pre Close0 Volume161 Open Interest12.50Strike Price0.00Turnover414.39%IV89.04%PremiumDec 20, 2024Expiry Date0.00Intrinsic Value100Multiplier5DDays to Expiry0.26Extrinsic Value100Contract SizeAmericanOptions Type0.1734Delta0.0739Gamma25.96Leverage Ratio-0.0775Theta0.0001Rho4.50Eff Leverage0.0021Vega
Kezar Life Sciences Stock Discussion
SEC· just
Kezar Life Sciences Announces Cessation of Enrollment and Dosing in the Phase 2b PALIZADE Trial of Zetomipzomib in Active Lupus Nephritis Patients
since I'm Evan McCullouch fans, and ever said he bought $Kezar Life Sciences (KZR.US)$ ... for biotech...
recently he just sold.
$Kezar Life Sciences (KZR.US)$
$LumiraDx (LMDX.US)$
No comment yet